Adalimumab treatment for SAPHO syndrome.
Salvador
S
Arias-Santiago
Daniel
D
Sanchez-Cano
José Luis
JL
Callejas-Rubio
María Antonia
MA
Fernández-Pugnaire
Norberto
N
Ortego-Centeno
D020083:Acquired Hyperostosis Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D013256:Steroids; D000069285:Infliximab; D000068879:Adalimumab